Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novo Nordisk B | Copenhagen | Healthcare | Pharmaceuticals | DKK 2.43T | 24x | 1.08 | DKK 545.20 | 2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 40.5% Upside | Upgrade to Pro+ | |
H Lundbeck B | Copenhagen | Healthcare | Pharmaceuticals | DKK 37.55B | 13.3x | 0.32 | DKK 39.64 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27.3% Upside | Upgrade to Pro+ | |
H Lundbeck AS | Copenhagen | Healthcare | Pharmaceuticals | DKK 37.55B | 13.3x | 0.32 | DKK 32.75 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ALK-Abello B | Copenhagen | Healthcare | Pharmaceuticals | DKK 32.03B | 39.5x | 0.57 | DKK 144.80 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27% Upside | Upgrade to Pro+ | |
Bavarian Nordic | Copenhagen | Healthcare | Pharmaceuticals | DKK 12.94B | 13.1x | -0.38 | DKK 166.10 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Stenocare AS | Copenhagen | Healthcare | Pharmaceuticals | DKK 8.83M | -0.2x | 0.01 | DKK 0.43 | -3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |